Member Info for hamiltonbro

Pumpky has sold out again : )

Good luck getting back in today !

Nai/DYOR

08/09/25 rns pumpky:

“Funding Commitment

As part of the Transaction, A2A Pharmaceuticals and its investors are committed to providing the majority of the funding requirement of the enlarged company over the next two years with an investment of £6 million.”

Nai/DYOR

Imagine they will rns it in the morning ?

Nai/DYOR

Reminder on the chart targets here :

https://www.youtube.com/watch?v=gj6i8VoosTk

5.57 mins in

Next target is 4.34p-5.25p : )

Anyone buying now can still double/treble/quadruple their money imho.

Nai/DYOR

MMS have no shares down here. They aren’t having mine for less than 11p.

Using sellers to fill buy orders last few trading days and then delaying publishing them.

Told you all we need sellers to move up. Volume is good and mms playing the sellers like fools, locking them out on the move up.

Into the 3’s tomorrow.

Nai/DYOR

Nai/DYOR

I’m going to watch it tonight.

Looks like the chart has broken out as predicted ! Next stop 4p.

Still 100% upside just to get to the Lyramid deal value, never mind the RTO or the Oncogeni deal.

Nai/DYOR

50,000 shares at the ask should work on a fill or kill order as 50k is the NMS !

They have to fill it or move it up.

Nai/DYOR

Imagine when the deals close. Not many shares to go around here as it is.

Nai/DYOR

So we have a had a round £10k and a round £15k buys today.

£15k one paid over and is the highest anyone has paid in over the last year.

All on the day we are going to get the presentation.

Feels like more than punters desperate to get in. We will find out why soon I’m sure.

Nai/DYOR

2.39p paid for over 409k shares. £10k buy.

Presentation in two hours.

Nai/DYOR

I do wonder how thick and stupid some people can be.

Selling a stock when people have paid over the asking price is just beyond belief.

The company has told us what it is worth and we will get further confirmation in the presentation later today.

Selling at less than 10p imho is just silly.

Nai/DYOR

Breakout coming. Move to 4-5p will be quick imho.

Nai/DYOR

Depends of you see the Lyramid/Oncogeni deals as a bonus or the RTO as the bonus.

We are getting 11p of cash/upside in the two aforementioned deals so for me, the RTO is just the icing on the cake so I am actually not too worried about the dilution.

I think a lot of investors are on the sidelines as they don’t know how to value ROQ. That is fair enough but I am seeing massive upside.

Nai/DYOR

Monday might be too late ? They live a 7am rns !

Nai/DYOR

Close around 2.5p likely.

Nai/DYOR

Epp style U reversal takes this straight to 4p.

I think that misshaped W gets filled soon up to 9p but only my honest opinion.

Nai/DYOR

No shares left at 2.3p.

Nai/DYOR

Also read page 3 in full here to get a better idea of the Lyramid sale and upside. $10.8m (5p per share as reiterated by Stephen West in the RTO announcement interview) for that asset can be seen as the minimum with this report saying it could be worth $50m to us shareholders on exit.

https://www.roquefortplc.com/sites/default/files/content-files/2024_SP_Angel_Roqeufort_05092024_FINAL.pdf

Nai/DYOR

No wonder coiled want to keep the stat-6 programme:

https://www.roquefortplc.com/sites/default/files/content-files/2024_SP_Angel_Roqeufort_NovemberFlashNote_FINAL.pdf

Industry interest in developing STAT-6 inhibitors

There is considerable industry interest in STAT-6 targeting treatments in the immunology

space. In 2023, Sanofi (SNA.EP) struck a deal with Recludix (Private) to licence a preclinical

program targeting STAT-6. The deal came with a US$125m upfront payment and potential

milestone payments totalling $1.2bn. The recent in vitro study generated by the Group is

similar to studies conducted by Recludix.

And:

Read bottom paragraph of page 2 : )

Nai/DYOR

Yes agreed cyber. Plus, the two deals that we will get exposure to worth a minimum of 11p per share in for free : )

Someone on x who has had a lot of recent multimeters calling this to 10p.

I agree.

Nai/DYOR